@FiercePharma: Top-read on FP Monday: Riled by $84,000 Sovaldi, Senate panel digs into Gilead's Pharmasset buy. Article | Follow @FiercePharma
@EricPFierce: Too bad Pfizer couldn't point to the Cork jobs when it was being savaged over its run at AstraZeneca. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Teva rebel investor Landa's gearing up for a proxy fight--and he can win, he says. Report | Follow @CarlyHFierce
> The High Court in Bombay, India, has upheld a compulsory license for Natco to manufacture a generic of Bayer's cancer drug Nexavar. Story
> Valeant Pharmaceuticals ($VRX) said today that it has filed a premerger notification with the U.S. Federal Trade Commission for its proposed acquisition of Allergan. Announcement
> Janssen will sell Pfizer's antidepressant Efexor XR in South Korea. Story
> GlaxoSmithKline ($GSK) has recalled about 10,600 bottles of its Panadol painkiller in Puerto Rico because the packaging was not found to be child-resistant. Story
> Salix Pharmaceuticals ($SLXP) and Progenics Pharmaceuticals ($PGNX) announced that the FDA has informed them it can approve Relistor subcutaneous injection for the treatment of opioid-induced constipation (OIC) in cancer patients based on the data they have submitted. Report
> Mallinckrodt ($MNK) and Questcor Pharmaceuticals ($QCOR) have set Aug. 14 shareholder meetings to vote on their proposed merger. Release
> Portugal-based Bial and Latin-American focused moksha8 have approved a license for the commercialization of eslicarbazepine acetate in Brazil and Mexico for the treatment of epilepsy. Release
Medical Device News
@FierceMedDev: Abbott continues evolution toward devices, planning to sell generics portfolio for $5.3B. Article | Follow @FierceMedDev
@StacyALawrence: RT @EmilyMFierce: I wrote a piece for @TheAtlantic about what it's like to have a rare voice disorder. Story | Follow @StacyALawrence
@VarunSaxena2: ICYMI: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go further. Story | Follow @VarunSaxena2
@MichaelGFierce: Trending on FierceDrugDelivery: @MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. Article | Follow @MichaelGFierce
@EmilyWFierce: Boston Scientific wins CE mark for next-generation drug-coated balloon catheter. Article | Follow @EmilyWFierce
> Novartis and Google team up to develop smart contact lenses. Article
> Abbott CEO: 'I don't feel the pressure to invert.' More
> St. Jude shells out $200M for chronic pain therapy manufacturer NeuroTherm. Report
Biotech News
@FierceBiotech: Targacept's Alzheimer's hopeful misses the mark in Phase II. Report | Follow @FierceBiotech
@DamianFierce: I love how Twitter has long been criticizing the froth in biotech but then Yellen steps in and it's like, Yo. | Follow @DamianFierce
@EmilyMFierce: Here's what reporters--and you--should look for in scientific studies. More from U.S. News | Follow @EmilyMFierce
> La Jolla leaps on NASH fervor thanks to some preclinical success. News
> Why isn't New York City a biotech hub? More
> Novartis plans to test Alzheimer's drugs in patients without symptoms. Story
Biotech Research News
> Genetic variant may protect against Alzheimer's. More
> Scientists reprogram stem cells into blood cells. Story
> Compound prevents blindness, diabetes in rodents. More
> Eli Lilly Alzheimer's study shows combo therapy clears more amyloid in mice. Article
> Vaccine prevents anthrax infection in preclinical tests. Item
Pharma Manufacturing News
> Glenmark to build $100M plant in North America. News
> Purdue moves forward with $59M plant in North Carolina. Item
> GSK investing $25M for Codexis manufacturing technology. Article
> Job-cutting Pfizer saves 100 jobs in U.K. Story
> PhRMA, BIO, GPhA ask court to trash California drug disposal law. Report
And Finally... Sanofi ($SNY) has donated $2.5 million to the Milken Institute School of Public Health at George Washington University in Washington, DC. Announcement